Terry Jo Vetters Bichell BoldMedicine
-
- Business News
Terry Jo Vetters Bichell has been the Director/Scientific Officer of the Angelman Biomarkers and Outcome Measures Alliance (A-BOM) (https://www.angelmanbiomarkers.org/about-us/) since its inception in 2016. Dr. Bichell earned a PhD in neuroscience from Vanderbilt University in 2016, studying gene-environment interactions in Huntington’s disease rodent models, but she has been involved in Angelman research since 2000, when her son, Lou, was diagnosed with Angelman syndrome.
In this episode of Bold Medicine, Terry Jo talks about her role in advancing Angelman syndrome research and what matters most to families in the Angelman syndrome community.
Terry Jo Vetters Bichell has been the Director/Scientific Officer of the Angelman Biomarkers and Outcome Measures Alliance (A-BOM) (https://www.angelmanbiomarkers.org/about-us/) since its inception in 2016. Dr. Bichell earned a PhD in neuroscience from Vanderbilt University in 2016, studying gene-environment interactions in Huntington’s disease rodent models, but she has been involved in Angelman research since 2000, when her son, Lou, was diagnosed with Angelman syndrome.
In this episode of Bold Medicine, Terry Jo talks about her role in advancing Angelman syndrome research and what matters most to families in the Angelman syndrome community.